For patients tolerating the drug who experience a decreases in glomerular filtration rate (GFR), new guidelines state reduced renal dosing is a safe option (17,18)
Tirzepatide is the only dual agonist among the established options here, acting on both GIP and GLP-1 receptors, and it is given as a weekly injection
Instead, they receive guidance from a medical team that understands the biology of weight, the psychology of eating, and the long-term nature of metabolic disease
It also suppresses glucagon secretion, which helps to lower glucose production by the liver
By acknowledging and learning from these accounts, healthcare providers can enhance their approach to managing Semaglutides side effects, ensuring that patients receive the most effective and comfortable care possible
Fortino the Philadelphia DIet Doctor and his team provide alternatives using the active ingredient Tirzepatide